TY - JOUR
T1 - Management of acute pancreatitis in the pediatric population
T2 - A clinical report from the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Pancreas Committee
AU - Abu-El-Haija, Maisam
AU - Kumar, Soma
AU - Quiros, Jose Antonio
AU - Balakrishnan, Keshawadhana
AU - Barth, Bradley
AU - Bitton, Samuel
AU - Eisses, John F.
AU - Foglio, Elsie Jazmin
AU - Fox, Victor
AU - Francis, Denease
AU - Freeman, Alvin Jay
AU - Gonska, Tanja
AU - Grover, Amit S.
AU - Husain, Sohail Z.
AU - Kumar, Rakesh
AU - Lapsia, Sameer
AU - Lin, Tom
AU - Liu, Quin Y.
AU - Maqbool, Asim
AU - Sellers, Zachary M.
AU - Szabo, Flora
AU - Uc, Aliye
AU - Werlin, Steven L.
AU - Morinville, Veronique D.
N1 - Funding Information:
This publication was supported by the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN); M.A.E.H. by the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) under award number R43 DK105640-01.
Publisher Copyright:
Copyright © 2017 ESPGHAN and NASPGHAN.
PY - 2018/1/1
Y1 - 2018/1/1
N2 - Background: Although the incidence of acute pancreatitis (AP) in children is increasing, management recommendations rely on adult published guidelines. Pediatric-specific recommendations are needed. Methods: The North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Pancreas committee performed a MEDLINE review using several preselected key terms relating to management considerations in adult and pediatric AP. The literature was summarized, quality of evidence reviewed, and statements of recommendations developed. The authorship met to discuss the evidence, statements, and voted on recommendations. A consensus of at least 75% was required to approve a recommendation. Results: The diagnosis of pediatric AP should follow the published INternational Study Group of Pediatric Pancreatitis: In Search for a CuRE definitions (by meeting at least 2 out of 3 criteria: (1) abdominal pain compatible with AP, (2) serum amylase and/or lipase values ≥3 times upper limits of normal, (3) imaging findings consistent with AP). Adequate fluid resuscitation with crystalloid appears key especially within the first 24 hours. Analgesia may include opioid medications when opioid-sparing measures are inadequate. Pulmonary, cardiovascular, and renal status should be closely monitored particularly within the first 48 hours. Enteral nutrition should be started as early as tolerated, whether through oral, gastric, or jejunal route. Little evidence supports the use of prophylactic antibiotics, antioxidants, probiotics, and protease inhibitors. Esophago-gastroduodenoscopy, endoscopic retrograde cholangiopancreatography, and endoscopic ultrasonography have limited roles in diagnosis and management. Children should be carefully followed for development of early or late complications and recurrent attacks of AP. Conclusions: This clinical report represents the first English-language recommendations for the management of pediatric AP. Future aims should include prospective multicenter pediatric studies to further validate these recommendations and optimize care for children with AP.
AB - Background: Although the incidence of acute pancreatitis (AP) in children is increasing, management recommendations rely on adult published guidelines. Pediatric-specific recommendations are needed. Methods: The North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Pancreas committee performed a MEDLINE review using several preselected key terms relating to management considerations in adult and pediatric AP. The literature was summarized, quality of evidence reviewed, and statements of recommendations developed. The authorship met to discuss the evidence, statements, and voted on recommendations. A consensus of at least 75% was required to approve a recommendation. Results: The diagnosis of pediatric AP should follow the published INternational Study Group of Pediatric Pancreatitis: In Search for a CuRE definitions (by meeting at least 2 out of 3 criteria: (1) abdominal pain compatible with AP, (2) serum amylase and/or lipase values ≥3 times upper limits of normal, (3) imaging findings consistent with AP). Adequate fluid resuscitation with crystalloid appears key especially within the first 24 hours. Analgesia may include opioid medications when opioid-sparing measures are inadequate. Pulmonary, cardiovascular, and renal status should be closely monitored particularly within the first 48 hours. Enteral nutrition should be started as early as tolerated, whether through oral, gastric, or jejunal route. Little evidence supports the use of prophylactic antibiotics, antioxidants, probiotics, and protease inhibitors. Esophago-gastroduodenoscopy, endoscopic retrograde cholangiopancreatography, and endoscopic ultrasonography have limited roles in diagnosis and management. Children should be carefully followed for development of early or late complications and recurrent attacks of AP. Conclusions: This clinical report represents the first English-language recommendations for the management of pediatric AP. Future aims should include prospective multicenter pediatric studies to further validate these recommendations and optimize care for children with AP.
KW - Endoscopy
KW - Fluid management
KW - Nutrition
KW - Pain control
KW - Protease inhibitors
KW - Surgery
UR - http://www.scopus.com/inward/record.url?scp=85039716233&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85039716233&partnerID=8YFLogxK
U2 - 10.1097/MPG.0000000000001715
DO - 10.1097/MPG.0000000000001715
M3 - Review article
C2 - 29280782
AN - SCOPUS:85039716233
SN - 0277-2116
VL - 66
SP - 159
EP - 176
JO - Journal of pediatric gastroenterology and nutrition
JF - Journal of pediatric gastroenterology and nutrition
IS - 1
ER -